InChI=1S/C20H20N4O4/c1- 12- 4- 7- 15(10- 13(12) 2) 24- 19(26) 17(18(25) 22- 20(24) 27) 11- 21- 23- 14- 5- 8- 16(28- 3) 9- 6- 14/h4- 11,21,23H,1- 3H3,(H,22,25,27) |
SBMRCXHMWMVWPF-UHFFFAOYSA-N |
CC1=C(C=C(C=C1)N2C(=O)C(=CNNC3=CC=C(C=C3)OC)C(=O)NC2=O)C |
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
View more via ChEBI Ontology
Outgoing
|
1-(3,4-dimethylphenyl)-5-[[(4-methoxyphenyl)hydrazo]methylidene]-1,3-diazinane-2,4,6-trione
(CHEBI:109707)
is a
barbiturates
(CHEBI:22693)
|
|
|